Nkarta, Inc. (NKTX)
2.75
+0.33
(+13.64%)
USD |
NASDAQ |
Apr 16, 15:32
Nkarta EPS Diluted (Quarterly) : -0.3702 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.742 |
| Allogene Therapeutics, Inc. | -0.1717 |
| ImmunityBio, Inc. | -0.0626 |
| Cullinan Therapeutics, Inc. | -0.8566 |
| Zenas BioPharma, Inc. | -5.172 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -27.41M |
| Total Expenses (Quarterly) | 27.41M |
| Enterprise Value | -27.34M |
| Earnings Yield | -51.16% |
| Normalized Earnings Yield | -51.16 |